Dogwood Therapeutics, Inc. (DWTX) Operating cash flow 2020–2025
Dogwood Therapeutics, Inc. (DWTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.6MFY2025 · since FY2020: -$3.9M → -$15.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.6M | -77.7% |
| FY2024 | -$8.8M | -80.5% |
| FY2023 | -$4.9M | +57.5% |
| FY2022 | -$11.5M | +26.9% |
| FY2021 | -$15.7M | -302.8% |
| FY2020 | -$3.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice